MARATTO

preprint

Esculentin-2CHa (GA30) mitigates copper-induced redox imbalance and behavioural deficit in Drosophila melanogaster

20241 citationOpen accessUniversity of Ibadan

Abstract

<title>Abstract</title> Excess copper ion (Cu<sup>2+</sup>) has been implicated in various pathological conditions involving oxidative stress and inflammation. This study investigated neuroprotective effects of esculentin-2CHa-(GA30) on copper-induced toxicity in <italic>Drosophila melanogaster</italic>. Flies were treated with esculentin-2CHa (5.0 and 7.5 µM/kg diet) and/or Cu<sup>2+</sup> (1mM) orally for 5 days. Effects of esculetin-2CHa-(GA30) on markers of redox-antioxidant status and neuro-behavioural activities were assessed. Esculetin-2CHa-(GA30) did not affect survival rate but reversed the effect of copper on eclosion rate. Esculetin-2CHa-(GA30) dose-dependently mitigated Cu<sup>2+</sup>-induced elevation of hydrogen peroxide (15.1–15.8%, P &lt; 0.05), thiobarbituric reactive substance (37.2–55.1%, P &lt; 0.01–0.001) and protein carbonyl (20.7–63.8%, P &lt; 0.05–0.001). Esculetin-2CHa-(GA30) ameliorated Cu<sup>2+</sup>-induced inhibition of catalase (1.5–1.7-fold, P &lt; 0.01–0.001), glutathione S-transferase activities (1.5–2.1-fold, P &lt; 0.01–0.001) and decline in non-protein thiols levels (13.6–27.7%, P &lt; 0.05). Esculetin-2CHa-(GA30) reduced Cu<sup>2+−</sup>induced elevation of monoamine oxidase (21.7–39.7%, P &lt; 0.05–0.01) and acetylcholinesterase (40.1–55.9%, P &lt; 0.01–0.001) activities. Copper-induced impaired locomotor activities were dose-dependently improved in esculentin-2CH-(GA30)-treated flies (21.4%, P &lt; 0.05 and 72.1%, P &lt; 0.01). Histological assessments indicated the ability of esculentin-2CHa-(GA30) to sequester Cu<sup>2+</sup> in the microglia. In conclusion, esculentin-2CHa-(GA30) exhibited its neuroprotective effects through improved balance of redox status and associated behavioural characteristics. Further studies to delineate molecular mechanisms underlying observed effects would be required.

Research topics

  • Cholinesterase and Neurodegenerative Diseases
  • Medicinal Plants and Neuroprotection
  • Trace Elements in Health

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21203/rs.3.rs-4368804/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.